It is a tripeptide made up of glutamate, cysteine and glycine, involved in cellular protection against oxidative damage and in various detoxification processes
Differences in protein abundance have been reported from a range of studies of blood plasma and sera from individuals with type 1 diabetes, before and after diagnosis [3,4,5,6,7,8,9]
Given that traditional antiepileptic drugs often focus on seizure control without addressing underlying neurodevelopmental issues, the use of metabolic modulators like DMI may offer a novel approach to treatment
Published research explores how the peptide affects gastrointestinal tissues, connective tissues, ligaments, tendons, muscles, and other biological systems
Restoring the central nervous system function
Sil, Bose Institute, India Reviewed by Jose Manuel Lerma-Cabrera, University of Almeria, Spain Robert Wade Siggins, Louisiana State University, United States Updates Copyright 2025 Lee, Lee and Kang